North York, Canada

Vilcy Parmar


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Vilcy Parmar

Introduction

Vilcy Parmar is a notable inventor based in North York, Canada. He has made significant contributions to the field of biomedical research, particularly in the area of blood cell lysis and microbial cell separation. His innovative work has led to the development of a patented method that enhances the efficiency of these processes.

Latest Patents

Vilcy Parmar holds a patent for "Methods and compositions for the selective lysis of blood cells and separation of microbial cells." This patent describes methods and compositions that allow for the selective lysis of eukaryotic cells, such as blood cells, while effectively separating microbial cells. The process involves adding a blood lysis reagent, which includes saponin and an alkaline buffer, to a sample. This mixture is then agitated, allowing for the separation of microbial cells through methods like centrifugation or filtration. The patent emphasizes the importance of preserving the integrity of microbial cells during the process, particularly when dealing with blood samples.

Career Highlights

Vilcy Parmar is currently associated with Qvella Corporation, where he continues to advance his research and development efforts. His work at Qvella focuses on innovative solutions in the field of diagnostics and cell separation technologies. His contributions have been instrumental in enhancing the capabilities of medical diagnostics.

Collaborations

Vilcy has collaborated with several professionals in his field, including Samad Talebpour and Aye Aye Khine. These collaborations have fostered a productive environment for innovation and have contributed to the success of their projects.

Conclusion

Vilcy Parmar's work exemplifies the impact of innovative thinking in the biomedical field. His patented methods for blood cell lysis and microbial cell separation represent a significant advancement in medical technology. His ongoing contributions at Qvella Corporation continue to shape the future of diagnostics and cell research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…